Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Dova Pharmaceuticals Inc (DOVA)

Dova Pharmaceuticals Inc (DOVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Dova Pharmaceuticals Inc 240 Leigh Farm Road Suite 245 Durham NC 27707 USA

www.dova.com P: 919-748-5975

Description:

Dova Pharmaceuticals, Inc. is a pharmaceutical company. It focuses on acquiring, developing and commercializing drug candidates for thrombocytopenia diseases. The company's drug candidate includes avatrombopag, an orally administered thrombopoietin receptor agonist which are in clinical stage. Dova Pharmaceuticals, Inc. is based in Durham, North Carolina.

Key Statistics

Overview:

Market Capitalization, $K 807,608
Shares Outstanding, K 28,802
Annual Sales, $ 10,360 K
Annual Net Income, $ -72,280 K
Last Quarter Sales, $ 3,520 K
Last Quarter Net Income, $ -17,060 K
60-Month Beta 2.74
% of Insider Shareholders 60.30%
% of Institutional Shareholders 33.03%
Float, K 11,434
% Float 39.70%

Growth:

1-Year Return 66.02%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Latest Earnings Date 11/14/19
Earnings Per Share ttm -2.56
EPS Growth vs. Prev Qtr -3.45%
EPS Growth vs. Prev Year 14.29%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

DOVA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -101.60%
Return-on-Assets % -67.21%
Profit Margin % -697.68%
Debt/Equity 0.41
Price/Sales 77.88
Price/Cash Flow N/A
Price/Book 15.58
Book Value/Share 1.80
Interest Coverage -37.45
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar